Clinical Trial Update: Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating RAY1225 for obesity in adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RAY1225

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: Obesity | Phase 3 | Status: RECRUITING